Regulator for price cap on anti-cancer drugs
Regulator for price cap on anti-cancer drugs
New Delhi: Drugs Controller General of India has recommended a price cap on anti-cancer medicines, a government source person familiar with the matter said on Wednesday.
“The regulator has written to the director general health services to include anti-cancer drugs in the list of essential medicines that are under price control," the person said.
The move is likely to hurt margins of companies such as GlaxoSmithKline Pharmaceuticals Ltd Eli Lilly and Co. Ltd, and Pfizer Inc., who have major drugs in the category.
A final decision on this issue will have to be taken by the group of ministers on pharmaceutical policy.
Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!